Bone-anchored hearing aid
||This article needs more medical references for verification or relies too heavily on primary sources. (May 2014)|
A bone-anchored hearing aid (BAHA) or bone-anchored hearing device, is a type of hearing aid based on bone conduction. It is primarily suited for people who have conductive hearing losses, unilateral hearing loss, single-sided deafness and people with mixed hearing losses who cannot otherwise wear 'in the ear' or 'behind the ear' hearing aids. They are more expensive than conventional hearing aids, and their placement involves invasive surgery which carries a risk of complications, although when complications do occur, they are usually minor.
- 1 Background
- 2 Use and operation
- 3 Surgical procedure
- 4 Everyday handling of skin at implant site
- 5 Indications for BAHA
- 6 Benefits
- 7 Complications
- 8 Special concerns in small children
- 9 Costs
- 10 Manufacturers
- 11 References
- 12 External links
Hearing loss is the most common physical disability in the industrialized world. Two of the causes of hearing loss are lack of function in the inner ear (cochlea) and when the sound has problems in reaching the nerve cells of the inner ear. Example of the first include age-related hearing loss and hearing loss due to noise exposure. A patient born without external ear canals is an example of the latter for which a conventional hearing aid with a mould in the ear canal opening would not be effective. Some with this condition have normal inner ear function, as the external ear canal and the inner ear are developed at different stages during pregnancy With normal inner anatomy, sound conducted by the skull bone improves hearing.
A vibrator with a steel spring over the head or in heavy frames of eyeglasses pressed towards the bone behind the ear has been used to bring sound to the inner ear. This has, however, several disadvantages, such as discomfort and pain due to the pressure needed. The sound quality is also impaired as much of the sound energy is lost in the soft tissue over the skull bone, particularly for the higher sound frequencies important for speech understanding in noise.
Patients with chronic ear infection where the drum and/or the small bones in the middle ear are damaged often have hearing loss, but difficulties in using a hearing aid fitted in the ear canal. Direct bone conduction through a vibrator attached to a skin-penetrating implant addresses these disadvantages.
In 1977, the first three patients were implanted with a bone-conduction hearing solution by Anders Tjellström at the Ear, Nose, and Throat Department at Sahlgrenska University Hospital in Gothenburg, Sweden. A 4-mm-long titanium screw with a diameter of 3.75 mm was inserted in the bone behind the ear, and a bone conduction hearing aid was attached.
The term osseointegration was coined by Professor Brånemark. During animal studies, he found the bone tissue attached to the titanium implant without any soft tissue in between. He also showed an such an implant could take a heavy load. His definition of osseointegration was "direct contact between living bone and an implant that can take a load".
The first clinical application of titanium was in oral surgery, where implants were used for retention of dentures. Brånemark sought an acoustic way to evaluate osseointegration. A patient with implants in the jaws was fitted with a bone vibrator on one of his implants. When tested, the patient experienced very loud sound even at low stimulation levels, indicating sound could propagate very well in the bone. It has later been shown by Håkansson that the sound transmission in bone is linear, indicating low distortion of the sound.
The implant in the bone is made of commercially pure titanium and will osseointegrate. The hearing instrument is impedance-matched. Osseointegration has been defined as the direct contact between living bone and an implant that can take a load, with no soft tissue at the interface.
Use and operation
Bone-anchored hearing aids use a surgically implanted abutment to transmit sound by direct conduction through bone to the inner ear, bypassing the external auditory canal and middle ear. A titanium prosthesis is surgically embedded into the skull with a small abutment exposed outside the skin. A sound processor sits on this abutment and transmits sound vibrations to the titanium implant. The implant vibrates the skull and inner ear, which stimulate the nerve fibers of the inner ear, allowing hearing.
Bone-conduction hearing solutions use the screw-shaped implant placed in the bone behind the ear through a minor surgical procedure. A skin-penetrating coupling, called an abutment, is secured to the implant in the bone. A sound processor attached to the abutment will transmit the sound by direct conduction through bone to the inner ear, bypassing the external auditory canal and middle ear. The implant vibrates the skull and inner ear, which stimulate the hair cells of the inner ear, allowing hearing.
The surgery is often performed under local anaesthesia and as an outpatient procedure. An important piece of information for patients is that if they for whatever reason are not satisfied with the BAHA solution, removing the implant is easy. No other ear surgical procedure is reversible like this.
The bone behind the ear is exposed through a U-shaped or straight incision or with the help of a specially designed BAHA dermatome. A hole, 3 or 4 mm deep depending on the thickness of the bone, is drilled. The hole is widened and the implant with the mounted coupling is inserted under generous cooling to minimize surgical trauma to the bone.
Some surgeons perform a reduction of the subcutaneous soft tissue. The rationale for this is to reduce the mobility between implant and skin to avoid inflammation at the penetration site. This reduction of the soft tissue has been questioned and some surgeons do not perform any or a minimum of it. The rationale for this is that any surgery will result in some scar tissue that could be the focus of infection. The infections seen early during the development of the surgical procedure could perhaps be explained by the lack of seal between implant and abutment allowing bacteria to enter the space. A new helium tight seal may be advantageous and prevent biofilm formation. This will also allow the surgeon to use longer abutments should a need exist. Three to six weeks later or even earlier, the audiologist will fit and adjust the hearing processor according to the patient's hearing level. The fitting will be made using a special program in a computer.
The original surgical procedure has been described in detail by Tjellström et al. 2001.
Everyday handling of skin at implant site
An area where skin is penetrated requires care and cleaning because of the risk of inflammation around the abutment. Daily cleaning is required.
Indications for BAHA
Chronic ear disease
This fairly common condition is often associated with continuous or intermittent drainage from the ear canal. These patients may also have a hearing loss and need amplification. A conventional air conduction aid with a mold placed in the ear canal opening may not be appropriate due to the drainage, and may even provoke drainage. If the hearing loss is significant an air conduction aid may have difficulty overcoming the dysfunction of the eardrum and middle ear bones. Bone conduction hearing device bypassing the middle ear may be a more appropriate treatment for these patients. Good transmission of sound in the bone, with reduced attenuation and distortion may be possible.
A person with unilateral hearing loss may have functional difficulty hearing even when the other ear is normal, particularly in demanding situations such as noisy environments and when several people are speaking the same time. A complication in single-sided deafness is hearing impairment in the hearing ear. Conventional ear surgery involves a risk of hearing loss due to the surgical procedure. Most ear surgeons are thus reluctant to perform surgery on an only hearing ear.[medical citation needed] The BAHA surgery avoids this risk and may be an appropriate treatment. An extended trial of a BAHA system with a headband prior to surgery led to more realistic expectations. In the trial, 50% of the candidates wished to proceed to surgery.
External ear canal problems
Irritation in the external ear canal due to inflammation or eczema may be a condition for which a conventional air conduction aid is not an appropriate treatment. Direct bone conduction may be an option.
Patients with malformations are not always suitable for reconstructive surgery. Treacher Collins syndrome patients may have significant malformations with ossicular defects and an abnormal route of the facial nerve. These structures, as well as the inner ear, could be in danger at surgery.
Patients with Down syndrome may have a narrow ear canal and middle ear malformation leading to impaired hearing. Some part of the cognitive delay seen in these children may be partly due to their poor hearing.
The surgery can only take place once the skull is at least 2.5 mm thick.[needs update] Children who suffer certain syndromes may have a slighter build, thinner bone, or unusual anatomy. Other children may have a thicker skull at a younger age, so it is difficult to give a specific age for surgery.
In Canada, stage-one surgery for BAHA has been implanted into children as young as 13 months at the Hospital for Sick Children in Toronto. Stage-two surgery has been done as early as 22 months. In the U.S., the Food and Drug Administration only approves BAHA implantation of children aged five years or older.
For infants and young children prior to surgery, the sound processor can be worn on a head band or soft band which the infant wears to hold it against the skull.
By bypassing the outer or middle ear, BAHA can increase hearing in noisy situations and help localise sounds. In addition to improved speech understanding, it results in a natural sound with less distortion and feedback compared with conventional hearing aids. The ear canal is left open for comfort, and helps to reduce any problems caused by chronic ear infections or allergies. In patients with single-sided sensorineural deafness, BAHA sends the sound by the skull bone from the deaf side to the inner ear of the hearing side. This transfer of sound gives a 360° sound awareness.
- Failure of osseointegration
- Chronic infection
- Soft tissue
Soft-tissue complications are much more common, and most are managed with topical treatments. Children are more likely to suffer both kinds of complications than adults. Sometimes, a second surgical procedure is required. Complications are less likely with good wound hygiene. Other drawbacks of BAHA include accidental or spontaneous loss of the bone implant, and patient refusal for treatment due to stigma.
Special concerns in small children
Hearing is of utmost importance for a normal speech and intellectual and social development. The skull bone in children is often very thin and softer than in the adult. Surgery is thus often delayed until the age of four to five years. In the meantime, the child with bilateral atresia can be fitted with a band around the head with a coupling for a BAHA. This is may be done at the age of one month. Infants at this age may tolerate this well.
In the US, the cost of the Baha device is about $4000. In the Netherlands, the cost of the device is around €3000 (in 2008). The cost of the titanium implant, surgery, and aftercare from surgeon and audiologist must also be considered.
|This section needs additional citations for verification. (May 2014)|
At present, four device brands are available: Vibrant (MED-EL GmbH), Cochlear Bone Anchored Solutions AB, Oticon Medical, and Sophono, Inc. The sound processors are basically the same, with differences in design, features, and attachment type.
- Janssen, RM; Hong, P; Chadha, NK (Sep 2012). "Bilateral bone-anchored hearing aids for bilateral permanent conductive hearing loss: a systematic review.". Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery 147 (3): 412–22. PMID 22714424.
- Banga, R; Lawrence, R; Reid, A; McDermott, AL (2011). "Bone-anchored hearing aids versus conventional hearing aids.". Advances in oto-rhino-laryngology 71: 132–9. PMID 21389713.
- Wazen, JJ; Wycherly, B; Daugherty, J (2011). "Complications of bone-anchored hearing devices.". Advances in oto-rhino-laryngology 71: 63–72. PMID 21389706.
- Raicevich, George; Burwood, Eric; Dillon, Harvey (2008). "Taking the pressure off bone conduction hearing aid users". Australian and New Zealand Journal of Audiology 30 (2): 113–8. doi:10.1375/audi.30.2.113.
- Mylanus, E.A.; Snik, A.F.; Cremers, C.W. (1994). "Influence of the thickness of the skin and subcutaneous tissue covering the mastoid on bone-conduction thresholds obtained transcutaneously versus percutaneously.". Scandinavian Audiology 23 (3): 201–3. doi:10.3109/01050399409047509. PMID 7997838.
- Tjellström, A.; Håkansson, B.; Granström, G. (April 2001). "Bone-anchored hearing aids: Current status in adults and children.". Otolaryngologic Clinics of North America 34 (2): 337–64. doi:10.1016/S0030-6665%2805%2970335-2. PMID 11382574.
- Pennings, R.J.E.; Gulliver, M.; Morris, D.P. (2011). "The importance of an extended preoperative trial of BAHA in unilateral sensorineural hearing loss: a prospective cohort study". Clinical Otolaryngology 36 (5): 442–9. doi:10.1111/j.1749-4486.2011.02388.x. PMID 21883961.
- Papsin, Blake C.; Sirimanna, Tony K.S.; Albert, David M.; Bailey, C. Martin (1997). "Surgical experience with bone-anchored hearing aids in children". The Laryngoscope 107 (6): 801–6. doi:10.1097/00005537-199706000-00015. PMID 9185737.
- Flynn, Mark C.; Sadeghi, Andre; Halvarsson, Glenn (2009). "Baha solutions for patients with severe mixed hearing loss". Cochlear Implants International. doi:10.1002/cii.385. PMID 19195004.
- Lin, Li-Mei; Bowditch, Stephen; Anderson, Michael J.; May, Bradford et al. (2006). "Amplification in the rehabilitation of unilateral deafness: Speech in noise and directional hearing effects with bone-anchored hearing and contralateral routing of signal amplification". Otology & Neurotology 27 (2): 172–82. doi:10.1097/01.mao.0000196421.30275.73. PMID 16436986.
- Hol, Myrthe K.S.; Snik, Ad F.M.; Mylanus, Emmanuel A.M.; Cremers, Cor W.R.J. (2005). "Long-term results of bone-anchored hearing aid recipients who had previously used air-conduction hearing aids". Archives of Otolaryngology—Head & Neck Surgery 131 (4): 321–5. doi:10.1001/archotol.131.4.321. PMID 15837900.
- Watson, G.J.; Silva, S.; Lawless, T.; Harling, J.L. et al. (2008). "Bone anchored hearing aids: A preliminary assessment of the impact on outpatients and cost when rehabilitating hearing in chronic suppurative otitis media". Clinical Otolaryngology 33 (4): 338–42. doi:10.1111/j.1749-4486.2008.01698.x. PMID 18983343.
- Snik, A.F.; Mylanus, E.A.; Proops, D.W.; Wolfaardt, J.F. et al. (December 2005). "Consensus statements on the BAHA system: where do we stand at present?". Annals of Otology, Rhinology, and Laryngology 114 (12 Supp. 195): 1–12. PMID 16619473.
- Håkansson, Bo (2011). "The future of bone conduction hearing devices". Advances in Oto-Rhino-Laryngology 71: 140–52. doi:10.1159/000323715. PMID 21389714.
- Lieu, Judith E. Cho (2004). "Speech-language and educational consequences of unilateral hearing loss in children". Archives of Otolaryngology—Head & Neck Surgery 130 (5): 524–30. doi:10.1001/archotol.130.5.524. PMID 15148171.